Finance

Lists
STAR:NSE
Strides Pharma Science Ltd
999,00 ₹
+2,95%
(+28,60) 1D
6 օգս, 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for STAR...
Open
966,00 ₹
High
1 011,80 ₹
Low
964,00 ₹
Mkt. cap
92,08 մլրդ
Avg. vol.
221,53 հզր
Volume
424,99 հզր
Dividend
0,50%
Quarterly dividend
1,25 ₹
Ex-dividend date
31 հլս, 2026 թ.
P/E ratio
15,01
52-wk high
1 231,00 ₹
52-wk low
768,65 ₹
EPS
66,55 ₹
Shares outstanding
89,55 մլն
No. of employees
4 հզր
Open
966,00 ₹
High
1 011,80 ₹
Low
964,00 ₹
Mkt. cap
92,08 մլրդ
Avg. vol.
221,53 հզր
Volume
424,99 հզր
Dividend
0,50%
Quarterly dividend
1,25 ₹
Ex-dividend date
31 հլս, 2026 թ.
P/E ratio
15,01
52-wk high
1 231,00 ₹
52-wk low
768,65 ₹
EPS
66,55 ₹
Shares outstanding
89,55 մլն
No. of employees
4 հզր
News stories
From sources across the web
Profile
Strides Pharma Science Limited is an Indian pharmaceutical company, headquartered at Bangalore. The company manufactures pharmaceutical products, over-the-counter drugs and nutraceuticals. Products include softgel capsules, hard-gel capsules, tablets and dry and wet injectables. The company has 15 manufacturing sites in six countries and marketing presence in 50 countries. The company partners with generic companies to supply retail and hospital generics in injectable products and softgels. The company's stock trades on the Bombay Stock Exchange and on the National Stock Exchange of India. Strides Arcolab changed name to Strides Shasun Ltd after an amalgamation of Shasun Pharmaceuticals with Strides Arcolab. In September 2014, the Board of Directors of both the companies had approved a scheme of amalgamation between the two companies. Arun Kumar is the founder and chairman, and has been on the board as managing director since its inception. Wikipedia
About Strides Pharma Science Ltd
CEO-
Employees3,54 հզր
Founded1990
HeadquartersԲանգալոր, Կառնատակա, Հնդկաստան
Sector-
Websitestrides.com
Last report
31 հլս, 2026 թ.
Fiscal period
Q1 2027
EPS / Est. (INR)
- / -
Revenue / Est. (INR)
12,65 մլրդ / 13,32 մլրդ
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
12,21 մլրդ
11,95 մլրդ
13,23 մլրդ
12,65 մլրդ
Cost of goods sold
5,15 մլրդ
4,63 մլրդ
7,19 մլրդ
4,95 մլրդ
Cost of revenue
5,15 մլրդ
4,63 մլրդ
7,19 մլրդ
4,95 մլրդ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,27 մլրդ
2,30 մլրդ
3,45 մլրդ
2,43 մլրդ
Operating expense
5,24 մլրդ
5,46 մլրդ
4,91 մլրդ
5,97 մլրդ
Total operating expenses
10,39 մլրդ
10,09 մլրդ
12,10 մլրդ
10,92 մլրդ
Operating income
1,82 մլրդ
1,85 մլրդ
1,13 մլրդ
1,73 մլրդ
Other non operating income
271,40 մլն
1,07 մլրդ
-1,66 մլրդ
48,90 մլն
EBT including unusual items
1,53 մլրդ
2,45 մլրդ
1,48 մլրդ
2,00 մլրդ
EBT excluding unusual items
1,62 մլրդ
2,49 մլրդ
502,07 մլն
1,36 մլրդ
Income tax expense
215,93 մլն
373,53 մլն
187,70 մլն
341,23 մլն
Effective tax rate
14,10%
15,22%
12,68%
17,09%
Other operating expenses
2,47 մլրդ
2,66 մլրդ
928,53 մլն
2,97 մլրդ
Net income
1,28 մլրդ
2,02 մլրդ
1,27 մլրդ
1,57 մլրդ
Net profit margin
10,45%
16,92%
9,59%
12,40%
Earnings per share
-
-
-
-
Interest and investment income
-
-
404,82 մլն
-
Interest expense
-461,27 մլն
-433,79 մլն
-130,82 մլն
-405,61 մլն
Net interest expenses
-461,27 մլն
-433,79 մլն
274,00 մլն
-405,61 մլն
Depreciation and amortization charges
496,43 մլն
506,23 մլն
532,49 մլն
563,99 մլն
EBITDA
2,31 մլրդ
2,25 մլրդ
1,55 մլրդ
2,15 մլրդ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps